Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2026-01-06 @ 2:40 PM
Study NCT ID:
NCT00743067
Status:
COMPLETED
Last Update Posted:
2017-07-26
First Post:
2008-08-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2009-05-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-08-26
First Submit QC Date:
None
Study First Post Date:
2008-08-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-24
Last Update Post Date:
2017-07-26
Last Update Post Date Type:
ACTUAL